TO Approved for public release, distribution unlimited

Similar documents
TO Approved for public release, distribution unlimited

TO Approved for public release, distribution unlimited

Effect of Vaccine, Route, and Schedule on Antibody

TO Approved for public release, distribution unlimited

TO Approved for public release, distribution unlimited

TO Approved for public release, distribution unlimited

LD 60 determinations.-in order to study the resistance of mice to H. RESISTANCE INDUCED AGAINST HISTOPLASMA CAPSULA TUM: QUANTITATIVE ASPECTS*

TO Approved for public release, distribution unlimited

Teclin ical information Agency

TO Approved for public release, distribution unlimited

Received for publication February 8, 1960

EXPERIMENTAL SALMONELLOSIS

TO Approved for public release, distribution unlimited

I.NCLASSIFIED. Reproduced by DOCUMENT SERVICE CENTER KNOTT BUILDING, DAYTON, 2, OHIO

SUSCEPTIBILITY OF SUCKLING MICE TO VARIOLA VIRUS

Experiment #1 TARGET Mouse Model Group. Report prepared by Paul Converse, Ph.D. and Eric Nuermberger, M.D. March 1, 2006

The First Department of Bacteriology and Department of Tuberculosis, National Institute of Health, Kamiosaki, Shinagawa-ku, Tokyo 141

UNCLASSIFIED. o ADm/e ARMED SERVICES TECHNICAL INFORMATION AGENCY ARLINGTON HALL STATION ARLINGTON 12, VIRGINIA UNCLASSIFIED

TO Approved for public release, distribution unlimited

N. A STUDY OF THE VIRULENCE OF THE BRUCELLA VACCINE STRAIN

TO Approved for public release, distribution unlimited

TO Approved for public release, distribution unlimited

TO Approved for public release, distribution unlimited

CONTRACTING ORGANIZATION: University of California Lawrence Berkeley National Laboratory Berkeley, CA 94720

Early Repair Processes in Marrow Cells Irradiated and Proliferating in Vivo1

UNCLASS8 n-fd \AD DOCUMENTATION, CENTER 11DEFENSE FOR SCIENTIFIC AND TECHNICAL INFORMATION / ~CAMERON STATION, ALEXANDRIA.

TO Approved for public release, distribution unlimited

Enzo Paoletti, Ph.D. Albany State Health Laboratory Albany, NY 12201

AFRL-RH-WP-TR

(From the Biological Department, Chemical Corps, Camp Derrick, Frederick, Maryland)

NEW LIMITATION CHANGE TO Approved for public release, distribution unlimited

111 II1 I 111 III ? 0 9, AD-A CT 31i931 ANNUAL REPORT D TIC RDMUNDO KRAISELBURD S AUGUST 28, 1991.

TITLE: Prevention and Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

Immunologically Induced and Elicited Local

THE EFFECT OF NUTRITIONAL DISTURBANCES ON THE SUSCEPTIBILITY OF MICE TO STAPHYLOCOCCAL INFECTIONS*

TO Approved for public release, distribution unlimited

TO Approved for public release, distribution unlimited

FACTORS INFLUENCING VARIOLA VIRUS GROWTH ON THE CHORIOALLANTOIC MEMBRANE OF EMBRYONATED EGGS

Medical Bacteriology- Lecture 10. Mycobacterium. Actinomycetes. Nocardia

Pasteurella tularensis for Macaca mulatta and Man

CHAPTER 4 IMMUNOLOGICAL TECHNIQUES

Medical Bacteriology- lecture 13. Mycobacterium Actinomycetes

TITLE: A PSCA Promoter Based Avian Retroviral Transgene Model of Normal and Malignant Prostate

The Applicability of the Hypothesis of Independent Action to Fatal Infections in Mice given Salmonella typhimurium by Mouth

Preparation of Salmonella typhimurium killed vaccine by Gamma irradiation

RELATIONSHIP TO RESISTANCE IN KLEBSIELLA PNEUMONIAE

TITLE: Antibody - Pretargeted Cytokine Therapy of Cancer. CONTRACTING ORGANIZATION: Fox Chase Cancer Center Philadelphia, Pennsylvania 19111

Organisms used. The routine test organism was a putrefactive anaerobe, Company, and Bacilus stearothermophilus, strain NCA 1518.

inoculated to give an initial viable count of approximately 104 to 105 cells per ml, and incubated at 37 C with shaking, or under the desired gas

INFLUENCE OF INGESTED FOODS ON THE ORAL TOXICITY IN MICE OF

Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D

Biotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:

STUDIES ON THE NUTRITION AND PHYSIOLOGY OF PASTEURELLA PESTIS V. INHIBITION OF GROWTH BY D-SERINE AND ITS REVERSAL BY VARIOUS COMPOUNDS

DDC AVAILABILITY NOTICE. This document has been approved for public release and sale; its distribution is unlimited.

functional term and is not descriptive of any particular class of serum proteins. Thus, any serum protein or substance which reacts with

AWARD NUMBER: W81XWH TITLE: Androgen Deprivation Therapy and Cognitive Impairment. PRINCIPAL INVESTIGATOR: Robert N. Pechnick, Ph.D.

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

EXPERIMENTAL PNEUMONIA IN MICE FOLLOWING THE INHALATION OF STREPTOCOCCUS H2EMOLYTICUS AND OF FRIEDLANDER'S BACILLUS.

AWARD NUMBER: W81XWH TITLE: Gulf War Illness as a Brain Autoimmune Disorder. PRINCIPAL INVESTIGATOR: Apostolos Georgopoulos, MD, PhD

Ma-, 1966 fj U. S. ARMY BIOLOGICAL LABCRATORIES FORT DETRICK, FREDERICK, MARYLAND

CONTRACTING ORGANIZATION: Regents of the University of Michigan Ann Arbor, MI 48109

U.S. ARMY FOREIGN SCIENCE AND TECHNOLOGY CENTER

CONTRACTING ORGANIZATION: Fred Hutchinson Cancer Research Center Seattle, WA 98109

Monitoring tuberculosis progression using MRI and stereology

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland Approved for public release; distribution unlimited

(44) is microconidiating, fluffy, inositolless, isoleucineless, and valineless.

C for 2 hr at 22,620 X G. The supernatant fluid. was discarded and the sediment resuspended to

NON-LACTOSE FERMENTING BACTERIA FROM. While B. coli is generally accepted as a satisfactory index of

(From the Department of Animal and Plant Pathology of The Rockefeller Institute for Medical Research, Princeton, New Jersey)

CHEMICAL STUDIES ON BACTERIAL AGGLUTINATION II. THE IDENTITY OF PRECIPITIN AND AGGLUTININ* BY MICHAEL HEIDELBERGER, PH.D., AND ELVIN A.

AWARD NUMBER: W81XWH TITLE: Treatment of Pain and Autonomic Dysreflexia in Spinal Cord Injury with Deep Brain Stimulation

TITLE: Reduction of Radiation- or Chemotherapy-Induced Toxicity by Specific Expression of Anti-Apoptotic Molecules in Normal Cells

INTRABULBAR INOCULATION OF JAPANESE ENCEPHALITIS VIRUS TO MICE

TO Approved for public release, distribution unlimited

Aerosol Particle Size and Infectivity

RECIPIENT: Lankenau Institute for Medical Research, Wynnewood, PA 19096

4 2OO&O0 1/3 L030ý. STINFO Copy EFFECT OF MONOMETHYLHYDRAZINE ON GLUCOSE LEVELS IN RATS AMRL-TR JULY 1976

CONTRACTING ORGANIZATION: University of Texas M.D. Anderson Cancer Center Houston, TX 77030

METABOLIC INJURY TO BACTERIA AT LOW TEMPERATURES

resulting from evaporation of the spray droplets and containing viable bacteria have measurable settling velocities. Under our

Characteristics of Mycobacterium

TITLE: Treatment of Dengue Virus Infection with Repurposed Pharmaceuticals that Inhibit Autophagy

Roles of microrna-mediated Drug Resistance in Tumor Stem Cells of Small Cell Lung Carcinoma

BACTERIAL INTERFERENCE

Growth and Metabolism of Live Vaccine Strain of Pasteurella tularensis

The Effects of Reiki on Bacteria Survivorship. Jordan Ciccone Central Catholic High School

COAGULATION OF HUMAN PLASMA BY PASTEURELLA PESTIS'

TITLE: Adipose Estrogen and Increased Breast Cancer Risk in Obesity: Regulation by Leptin and Insulin

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

N ~~Translation No. f'

UNCLASSIFIED AD "DFFNSE DOCUMENTATION CENTER FOR SCIENTIFIC AND TECHNICAL INF;ORMATION CAMERON STATION, AIEXANDHIA. VIRGINIA UNCLASSHFIED

Serial No. 366,637. Filing Date 30 December 1994 NOTICE

against phage B was prepared by intravenous inoculation of 5 pound rabbits CORYNEBACTERIUM DIPHTHERIAE1

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

By:Reham Alahmadi NOV The production of antibodies and vaccination technology

THE CYTOPATHOGENIC ACTION OF BLUETONGUE VIRUS ON TISSUE CULTURES AND ITS APPLICATION TO THE DETECTION OF ANTIBODIES IN THE SERUM OF SHEEP.

TITLE: Managing Menopausal Symptoms in Breast Cancer Survivors

1) The fate of tubercle bacilli in rats when they are administered intra-

Transcription:

UNCLASSIFIED AD NUMBER AD450109 NEW LIMITATION CHANGE TO Approved for public release, distribution unlimited FROM Distribution authorized to U.S. Gov't. agencies only; Specific Authority; Aug 1964. Other requests shall be referred to the Army Biological Laboratories, Attn: Technical Releases Branch, Fort Detrick, MD 21701. AUTHORITY BODRL, per Dept/Army ltr dtd 27 Sep 1971 THIS PAGE IS UNCLASSIFIED

NOTICE: When government or other drawings, specifications or other data are used for any purpose other than in connection with a definitely related government procurement operation, the U. S. Government thereby incurs no responsibility, nor any obligation whatsoever; and the fact that the Government may have formulated, furnished, or in any way supplied the said drawings, specifications, or other data is not to be regarded. by implication or otherwise as in any manner licensing the holder or any other person or corporation, or conveying any rights or permission to manufacture, use or sell any patented invention that may in any way be rela'ted thereto.

...... TECHNICAL MANUSCRIPT15 ffiffffl ANTIGENICITY OF IRRoADIATED PASTEURELLA TULARENSIS VACCINES 6 IN MICE 12-CD Ml:a AUGUST 1964DC DOC-IRA C *UNIPTED STATES ARMY BIOLOGTICAL LABORATORIES FORT DETRICK I.~s MWIa Hie Copy

U.S. ARMY BIOLOGICAL LABORATORIES Fort Detrick, Frederick; Maryland TECHNICAL MANUSCRIPT 153 ANTIGENICITY OF IRRADIATED PASTEURELLA TULARENSIS VACCINES IN MICE Milton Gordon David M. Donaldson Leonard Green Medical Investigation Division DIRECTOR OF MEDICAL RESEC}CH Project 1AO12501B02801 August 1964 1

2 This publication or any portion thereof may not be reproduced without specific authorization from the Commanding Officer, U. S. Army Biological Laboratories, ATTN: Technical Releases Branch, Technical Information Division, Fort Detrick, Frederick, Maryland. 21701. However, DDC is authorized to reproduce the publication for U. S. Government purposes. The inforia'lion in this publication has not been cleared for release to the public. DDC AVAILABILITY NOTIQE I "Qualified requestora may obtain copies of this publication directly from DDO. Foreign announdcment and dissemination of this publication by DDC is limited. " ~ II

ABSTRACT Viable attenuated tularemia vaccines have been shown to be effective in immunizing mice and other animals against challenge with highly virulent Pasteurella tularensis. Preparations made nonviable by the action of heat or chemicalo,however, induce little or no re-i sistance to challenge with even small numbers of virulent organisms. In these studies, vaccines rendered nonviable by the action of ionizing radiation produced levels of immunity such that 20 to 30 per cent of immunized mice survived intraperitoneal challenge with moderate doses of the highly virulent SCHU S4 strain of P. tularensis. Both x- and electron beam-irradiation were effective in preparing the vaccine, which contained from 1.4 x 108 to 4.0 x l09 nonviable organisms per milliliter.

k Nonviable tularemia vaccines generally have proved to be ineffective for protecting laboratory animals* against challenge with a highly virulent strain. This ineffectiveness may be caused by heat or chemicals used to render the organisms nonviable. It seemed reasonable to suppose that antigenicity would be retained to a greater extent if the organisms were killed by irradiation rather than by chemicals or heat. This supposition is based on the hypothesis that under conditions that inhibit the indirect effects of irradiation, damage occurs primarily in the genetic material of the cell, and to a lesser extent to(other structures of the cell. Precedents for the effectiveness of irradiated vaccines may be found in the reports of Donaldson and Mitchell, 1 of Polley, 2 and of Carpenter and his associates. 3 The latter authors have demonstrated that irradiated tubercle bacilli were as effective as BCG vaccine in protecting mice against infection with this organism. In the present study the highly virulent SCHU S4 strain of Pasteurella tularensis was used for vaccine preparation and challenge. In some of the initial experiments an attenuated strain, designated LVS, was also used for vaccine preparation. The organisms were grown at 370C for 24 hours on the surface of an agar medium containing peptone, yeast extract, orotic acid, spermidine phosphate, histidine, cysteine hydrochloride and glucose. Cells were washed from the agar with 0.1 per cent gelatin-saline; the resulting suspensions contained in the order of 1010 viable organisms per milliliter as determined by plate counts. Two types of ionizing radiation were used to render bacterial suspensions nonviable: (a) x-rays produced by a 1 million electron volt Maxitron machine, and (b) an electron beam generated by a 3 million electron volt Van de Graaff accelerator. Because high doses of irradiation are necessary to sterilize these suspensions, beta-mercaptoethylamine, also referred to as cysteamine, was added to the suspensions at a final concentration of 0.02 M prior to irradiation to minimize the indirect effects of irradiation, that is, to scavenge free radicals produced upon irradiation of water. Following irradiation, the suspensions were tested for sterility, diluted tenfold in gelatin-saline, and injected intraperitoneally in 1.0 milliliter amounts into 18- to 20-gram white mice. The mice were challenged intraperitoneally two weeks later with virulent SCHU S4 organisms and observed for 21 dcys. Table I presents the results of an initial x-ray experiment. The first two lines of this table point out that if the dose of irradiation is insuf- :icient to sterilize the suspension, the surviving viable attenuated organiszus can immnunizt: mice. The mouse responses listed in the last column are reslts of a 1:10 dilt tlon of the irradiated preparation. The second line In condicting the research reported herein, the investigators adhered to "Principles of Laboratory Animal Care" as established by the National Society for Medical Research. PRECEDING PAGE BLANK

6 TABLE I. RELATIONSHIPS AMONG CELL CONCENTRATION, IRRADIATION DOSE, AND IMMUNIZING CAPACITY ImmunizingA XRay Dose Viable Cells/ml Viable Cells/ml Mouse zing (-ray Before After Strain (r) Irradiation Irradiation Response LVS Z0,000 4.03 x 1 0e 790 Immunized LVS 30,000 1.03 x 10 0 Not Immunized SCH8U S4 30,000 4.0 x 106 320 Death SCHU S4 40,000 4.0 x 106 0 Not Immunized SCHU S4 300,000 1.67 X 1010 160 Death SCHU S4 600,000.1.67 x 1010 0 Immunized indicates that 165 killed organisms will not immunize mice. The interpretation of "immunized" was based on 80 per cent of the animals in the first group surviving challenge of approximately 100 LD 50 ; the interpretation of "not immunized" was based on survival of only 10 per cent of the group. The second two lines point out that 32 viable SCHU S4 organisms killed all of the animals during the immunization period, whereas 4 x 105 killed organisms were ineffective in inducing immunity; all animals succumbed to challenge in this fourth group. In the next to the last line 16 viable virulent organisms killed 80 per cent of the mice prior to challenge. The last line shows that approximately 10 9 irradiated SCH1U S4 organisms induced "immunity" -- 50 per cent of the mice survived challenge. The results of this initial tork indicated that ionizing radiation was applicable to this system. Table II presents the results of challenge of mice immunized with x- irradiated SCHU S4 Pasteurella tularensis. The concentration of organisms ranged from 3 x 108 to 4 x 109- organisms per milliliter; the dose of irradiation was ane million roentgens. The figures represent the combined results of seven replicate vaccine preparations. The per cent mortality of immunized mice, given in the center column is the response to challenge with approximately 200 intraperitoneal LD 5 0. The figures in parentheses refer to the range of individual results.

7 TABLE 11. IMMUJNOGFUICITY OF X-IPfADIATED VACCINE IN MICE Mortality Per Cent Average Day of X-Irradiated 71/89 80 1i.8 Vaccine (50-95) (9.9-15.2) None 68/68 100 4.4 (4.0-4.7) Preparations of pherol-lld l PrAteurella tularensis, which contained 7.5 x log organisms per milliliter, were used to Immunize mice, but failed to result in any survivors following challenge with moderate doses of SCHU S4 organisms. The average day of death of this group of mice was about - -~ 7.4 days. Vaccines have also been prepared using an electron beam to render organisms..no.viable. - Table IlIT.points. out the similar results of x- and electron beamirradiation on the efficacy of vaccine preparations. Five electron beam vacci-es were prepared in a manner similar to the x-ray preparations. The vaccines contained frora approximately 108 to l0o organisms per milli.liter and were irradiated with 1.6 million rad. Groups of mice were immunized and. challenged two weeks later with from 100 to 200 LD 50 Off SCHU S4 organisms. The compeitiive results presented in Table III demonstrate that electron beam-irradiation is at least as good as x-irradiation for preparing vaccines. An important consideration in these studies is the assurance of complete sterility of-irradiated suspensions because viable attenuated organisms are capable of inducing an appreciable degree of immunity. Proof of nonviability of irradiated vaccines was based on the following pbservations: (a) no colonies developed when irradiated suspensions were plated on solid medium, (b) viable Pasteurella tularensis could not'be isolated from the lung, liver, or spleen of mice sacrificed on the first, third, sixth, *-r tenth cday following immunization, (c) administration of streptomycin to mice starting one day before and ending six days after a sangle immunizing injection did not interfere with the development of immunity. Such streptomycin

8 TABLE III. COMPARATIVE IMMUNOGENICITY OF X- AND EIECITRON BEAM- IRRADIATED VACCINES IN MICE Mortality Per Cent Average Day of Ratio Mortality Death SX-Irradiated 71/89 80 11.8 Vaccine (50-95) (9.9-15.2) Electron Beam- 164/236 69 12.8 I-r'nrlater! (50-100) (7.6-15.6) Vaccine 4.5 None 117/117 100 (3.9-5.4). treatment inhibits the development of immunity that normally follows administration of leas than 10i viable attenuated organisms. Irradiated vaccines retained immunogenicity after seven days at 50c, but had lost this immunogen±city by the fiftieth day of storage. ýrz

9 LITERATURE CITED 1. Donaldson, D.M., and Mitchell, J.R. "Immunization against Ehrlich's ascites carcinoma with x-irradiated tumor cells," Proc. Soc. Exptl. Biol. Med. 101:204-207, 1959. 2. Polley, J.R. "The use of gamma radiation for the preparation of virus vaccines," Can. J. Microbiol. 8:455-459, 1962. 3. Carpenter,C.M.; Naylor-Foote, A.W.C.; Taplin, G.V.; Lawrence, C.A.; and Drake, C.L. "Preliminary report on vaccines prepared from gammairradiated Mycobacterium tuberculosis and Brucella suis," Am. Rev. Tuberc. 79:374-377, 1959.